BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

iMedicor and MedLink Announce Partnership


5/3/2010 12:23:15 PM

NEW YORK, NY--(Marketwire - May 03, 2010) - MedLink (OTCBB: MLKNA), a leading healthcare IT provider of Electronic Health Record (EHR), practice management, and clinical integration software to the medical community announced today a partnership with iMedicor (OTCBB: VMCI). The partnership will provide a natural synergy of combined solutions that will enable enhanced information exchange capabilities to increase the efficacy of the RHIO Financial Sustainability Model by integrating the iMedicor information exchange portal and MedLink TotalOffice solution to facilitate secure messaging and CCR/ CCD exchange for its users. In addition, TotalOffice users will have access to iMedicor's ClearLobby platform that will provide informative, product specific content on new drugs and medical devices enabling users to directly communicate electronically with the manufacturers to order samples, ask questions and set up onsite meetings. ClearLobby establishes an additional revenue driver to the RHIO sustainability model, allowing for RHIOs to minimize their reliance on grant funding to provide a comprehensive health information exchange to its members.

iMedicor's pharma marketing platform, "ClearLobby," offers the first of its kind physician / pharma electronic communication system resulting in interactions that are much more meaningful and efficient. ClearLobby changes the dynamic of these relationships by placing control squarely in the hands of the physician. At the same time, the interaction between the physician and the pharma becomes more cost effective because ClearLobby is able to distribute critical product information and samples directly to the targeted user base.

About iMedicor

iMedicor is the only HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to healthcare providers and patients. The iMedicor portal also enables doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images in a secure, HIPAA compliant environment; allows disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; and allows pharmaceutical companies to deliver customized marketing programs to healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner. More information on iMedicor is available at www.imedicor.com.

About MedLink

MedLink is a healthcare IT company that provides the medical community with products and services designed to help create, manage, and share medical information. The company's flagship product, MedLink TotalOffice EHR 3.1, a CCHIT Certified® 08 Ambulatory EHR, provides physicians with full EHR and practice management functionality. For more information regarding MedLink's products and services, please visit www.medlinkus.com.

Safe Harbor Statement
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, outlined in our 2009 Annual Report on Form 10-K available through www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.


Contact:
Jameson Rose
(631) 342-8800
Email Contact




Read at BioSpace.com

iMedicor
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->